Kidney Transplantation -Guidelines

-

 IN WARD ON ADMISSION:

  • Admission in ward
  • History and Physical examination 
  • Send--CBC, RFT, ELECTROLYTES, LFT, CRP, PROCALCITONIN, COAGULATION, URINE CULTURE, BLOOD CULTURE, URINE ROUTINE, URINE PCR, CMR IgG, CXR, ECG, CROSS MATCH (4 UNITS PRBC)

Comments

Post a Comment

Popular posts from this blog

Assessment of Reflexes (New Born)

-
Image
  Reflexes of Eye 👁️: 1. Blinking : Infant blink at sudden appearance of bright light or approach of any object towards eye 👁️. Age of Appearance : Birth Age of Disappearance : Does not disappear 2. Pupillary Reaction: Pupil 👀constricts when bright light falls on it. Age of Appearance : Birth Age of Disappearance : Does not disappear 3. Doll's 👁️Eye: As head is moved to right or left, eyes 👀 lag behind and do not immediately adjust to new position. Age of Appearance : Birth  Age of Disappearance : 3-4 months Reflexes of Nose👃:  1. Sneeze 🤧 : Spontaneous response of nasal 👃 passage to any irritant. Age of Appearance : Birth Age of Disappearance : Does not disappear 2. Glabellar : Tapping briskly on bridge of 👃 nose (Glabella) causes eyes to close tightly. Age of Appearance: Birth  Age of Disappearance : Does not disappear  Reflexes of 👄 Mouth:  1. Rooting : The infant turns his head towards any object that touches his cheek 😊and actively seeks t...
Read more

Enoxaparin Sodium (Enclex)

-
 Composition:     Enclex 40 : Each prefilled syringe contains Enoxaparin Sodium IP -40mg Water for injection IP -0.4ml   Enclex 60 : Each prefilled syringe contains  Enoxaparin sodium Sodium IP -60mg Water for injection IP - 0.6ml Dosage form: Pre-filled syringe  Pharmacology :  Enoxaparin is a low-molecular weight heparin ,which has anti- thrombotic properties .In humans, enoxaparin given as a subcutaneous dose of 1.5 mg/kg is characterized by a higher ratio of anti- Factor X a to anti-Factor II a activity. Distribution:         The volume of distribution of anti- Factor Xa activity is about 4.3 litres Metabolism:   Enoxaparin Sodium is primarily metabolized in the liver by desulfation and /or depolymerization to lower molecular weight species with much reduced biological potency.Renal clearance of active fragments represents about 10% of the administered dose and total renal excretion of active and non-active fragments 40% ...
Read more